The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Open accessAbstract
The simultaneous intake of food and drugs can have a strong impact on drug release, absorption, distribution, metabolism and/or elimination and consequently, on the efficacy and safety of pharmacotherapy. As such, food-drug interactions are one of the main challenges in oral drug administration. Whereas pharmacokinetic (PK) food-drug interactions can have a variety of causes, pharmacodynamic (PD) food-drug interactions occur due to specific pharmacological interactions between a drug and particular drinks or food. In recent years, extensive efforts were made to elucidate the mechanisms that drive pharmacokinetic food-drug interactions. Their occurrence depends mainly on the properties of the drug substance, the formulation and a multitude of physiological factors. Every intake of food or drink changes the physiological conditions in the human gastrointestinal tract. Therefore, a precise understanding of how different foods and drinks affect the processes of drug absorption, distribution, metabolism and/or elimination as well as formulation performance is important in order to be able to predict and avoid such interactions. Furthermore, it must be considered that beverages such as milk, grapefruit juice and alcohol can also lead to specific food-drug interactions. In this regard, the growing use of food supplements and functional food requires urgent attention in oral pharmacotherapy. Recently, a new consortium in Understanding Gastrointestinal Absorption-related Processes (UNGAP) was established through COST, a funding organisation of the European Union supporting translational research across Europe. In this review of the UNGAP Working group "Food-Drug Interface", the different mechanisms that can lead to pharmacokinetic food-drug interactions are discussed and summarised from different expert perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–274 of 274
Effects of soy containing diet and isoflavones on cytochrome P450 enzyme expression and activity
Ronis, M. J. J. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1206562 · Cited by 71
Pentafragka, C., Symillides, M., McAllister, M. S., Dressman, J., Vertzoni, M., & Reppas, C. I. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12999 · Cited by 71
Self-citationInfluence of fruit juices on drug disposition: discrepancies betweenin vitroand clinical studies
Farkas, D., & Greenblatt, D. J. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.4.381 · Cited by 70
Schug, B. S., Brendel, E., Wolf, D., Wonnemann, M., Wargenau, M., & Blume, H. H. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00008-8 · Cited by 70
Konishi, T., Satsu, H., Hatsugai, Y., Aizawa, K., Inakuma, T., Nagata, S., Sakuda, S., Nagasawa, H., & Shimizu, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705804 · Cited by 69
Dietary Restriction, Tyramine, and the Use of Monoamine Oxidase Inhibitors
Shulman, K. I., Walker, S. E., MACKENZIE, S., & Sandra, K. (1989) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198912000-00002 · Cited by 69
Lennernäs, H. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9000876 · Cited by 67
The effect of dietary protein on the efficacy of L‐dopa
Tsui, J. K. C., Ross, S., Poulin, K., Douglas, J., Postnikoff, D., Calne, S. M., Woodward, W., & Calne, D. B. (1989) · Neurology · doi:10.1212/wnl.39.4.549 · Cited by 66
Edelbroek, M. A. L., Horowitz, M., Wishart, J. M., & Akkermans, L. M. A. (1993) · PubMed · Cited by 66
Influence of urine pH and urinary flow on the renal excretion of memantine
Freudenthaler, Meineke, Schreeb, Boakye, Gundert-Remy, & Gleiter (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00819.x · Cited by 64
Drug Binding and Solubility in Milk
Macheras, P. E., Koupparis, M. Α., & Antimisiaris, S. G. (1990) · Pharmaceutical Research · doi:10.1023/a:1015881103340 · Cited by 63
Al‐Salami, H., Butt, G., Tucker, I. G., Škrbić, R., Goločorbin-Kon, S., & Mikov, M. (2008) · Archives of Drug Information · doi:10.1111/j.1753-5174.2008.00006.x · Cited by 63
Dietary restriction, tyramine, and the use of monoamine oxidase inhibitors.
Shulman, K. I., Walker, S., MACKENZIE, S., et al. (1989) · PubMed · Cited by 63
Hussein, M. O., Hoad, C. L., Wright, J. W., Singh, G., Stephenson, M. C., Cox, E. F., Placidi, E., Pritchard, S. E., Costigan, C. M., Ribeiro, H. S., et al. (2015) · Journal of Nutrition · doi:10.3945/jn.114.204339 · Cited by 63
Self-citationEffect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumors
Willemsen, A. E. C. A. B., Lubberman, F. J. E., Tol, J., Gerritsen, W. R., van Herpen, C. M. L., & van Erp, N. P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.03.002 · Cited by 63
Lactobacillus rhamnosus infection in a child following bone marrow transplant
Kalima, P., Masterton, R. G., Roddie, P. H., & Thomas, A. E. (1996) · Journal of Infection · doi:10.1016/s0163-4453(96)91622-9 · Cited by 62
VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body
Yamamoto, H., Takada, T., Yamanashi, Y., Ogura, M., Masuo, Y., Harada‐Shiba, M., & Suzuki, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-00685-9 · Cited by 62
Meal Composition Effects on the Oral Bioavailability of Indinavir in HIV-Infected Patients
Carver, P. L., Fleisher, D., Zhou, S. Y., Kaul, D. R., Kazanjian, P. H., & Li, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018880726035 · Cited by 59
Targeted Drug Delivery to Lymphocytes: A Route to Site-Specific Immunomodulation?
Trevaskis, N. L., Charman, W. N., & Porter, C. J. H. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100259a · Cited by 59
Self-citationKoziolek, M., Görke, K., Neumann, M., Garbacz, G., & Weitschies, W. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.004 · Cited by 57
Self-citationYamasaki, K., Hyodo, S., Taguchi, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180404 · Cited by 56
Trevaskis, N. L., Shackleford, D. M., Charman, W. N., Edwards, G. A., Gardin, A., Appel‐Dingemanse, S., Kretz, O., Galli, B., & Porter, C. J. H. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9860-z · Cited by 55
Self-citationMunday, R. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200373u · Cited by 52
Schug, B. S., Brendel, E., Wonnemann, M., Wolf, D., Wargenau, M., Dingler, A., & Blume, H. H. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0444-7 · Cited by 50
Second generation H1 - antihistamines interaction with food and alcohol—A systematic review
Paśko, P., Rodacki, T., Domagała-Rodacka, R., Palimonka, K., Marcinkowska, M., & Owczarek, D. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.008 · Cited by 50
Glycation Alters Ligand Binding, Enzymatic, and Pharmacological Properties of Human Albumin
Baraka-Vidot, J., Planesse, C., Meilhac, O., Militello, V., van den Elsen, J. M. H., Bourdon, E., & Rondeau, P. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00273 · Cited by 48
Erokhova, L., Hörner, A., Ollinger, N., Siligan, C., & Pohl, P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.706986 · Cited by 47
White Paper AGA: Gastroparesis: Clinical and Regulatory Insights for Clinical Trials
Pasricha, P. J., Camilleri, M., Hasler, W. L., & Parkman, H. P. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.04.011 · Cited by 47
Sandberg, T. H., Nilsson, M., Poulsen, J. L., Gram, M., Frøkjær, J. B., Østergaard, L. R., & Drewes, A. M. (2015) · Abdominal Imaging · doi:10.1007/s00261-015-0475-z · Cited by 46
Assessment of Disintegration and Dissolution of Dosage Forms In Vivo Using Gamma Scintigraphy
WILSON, C. G., & Washington, N. (1988) · Drug Development and Industrial Pharmacy · doi:10.3109/03639048809151971 · Cited by 45
Trevaskis, N. L., McEvoy, C. L., McIntosh, M. P., Edwards, G. A., Shanker, R. M., Charman, W. N., & Porter, C. J. H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0083-0 · Cited by 44
Self-citationHuman postprandial gastric emptying of indigestible solids can occur unrelated to antral phase III
Stotzer, & Abrahamsson (2000) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2000.00218.x · Cited by 44
A Mouse Model to Evaluate the Impact of Species, Sex, and Lipid Load on Lymphatic Drug Transport
Trevaskis, N. L., Caliph, S. M., Nguyen, G., Tso, P., Charman, W. N., & Porter, C. J. H. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1000-0 · Cited by 44
Self-citationGershkovich, P., Qadri, B., Yacovan, A., Amselem, S., & Hoffman, A. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.04.006 · Cited by 44
Digenis, G. A., Sandefer, E. P., Page, R. C., Doll, W. J., Gold, T. B., & Darwazeh, N. B. (2000) · Pharmaceutical Research · doi:10.1023/a:1007568900147 · Cited by 42
Chalet, C., Rubbens, J., Tack, J. F., Duchateau, G. S. M. J. E., & Augustijns, P. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12929 · Cited by 42
Self-citationLawless, E., Griffin, B. T., O’Mahony, A., & O’Driscoll, C. M. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1578-x · Cited by 41
Trevaskis, N. L., Shanker, R. M., Charman, W. N., & Porter, C. J. H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0199-2 · Cited by 41
Self-citationEffects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin
Anguizola, J. A., Basiaga, S. B. G., & Hage, D. S. (2013) · Current Metabolomics · doi:10.2174/2213235x1130100005 · Cited by 40
Näßl, A., Rubio‐Aliaga, I., Sailer, M., & Daniel, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026407 · Cited by 38
Mikov, M., Đanić, M., Pavlović, N., Stanimirov, B., Goločorbin-Kon, S., Stankov, K., & Al‐Salami, H. (2017) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-017-0441-y · Cited by 38
Guimarães, M., Statelova, M., Holm, R., Reppas, C. I., Symillides, M., Vertzoni, M., & Fotaki, N. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12955 · Cited by 38
Self-citationTrevaskis, N. L., Porter, C. J. H., & Charman, W. N. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008102 · Cited by 37
Self-citationAntibiotic Susceptibility of Bifidobacterial Strains Distributed in the Japanese Market
Xiao, J., Takahashi, S., Odamaki, T., Yaeshima, T., & Iwatsuki, K. (2010) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.90659 · Cited by 37
Steingoetter, A., Sauter, M. M., Curcic, J., et al. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0343-x · Cited by 37
Khoo, S., Prankerd, R. J., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10045 · Cited by 36
Self-citationThe effect of oral lipids and circulating lipoproteins on the metabolism of drugs
Patel, J. P., & Brocks, D. R. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903176439 · Cited by 36
Lespine, A., Chanoit, G. P. A., Bousquet‐mélou, A., Lallemand, E. A., Bassissi, F., Alvinerie, M., & Toutain, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.003 · Cited by 35
Jones, B. E., Basit, A. W., & Tuleu, C. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.034 · Cited by 35
Self-citationRole of Protein Binding in Pharmacokinetics
Mehvar, R. (2005) · American Journal of Pharmaceutical Education · doi:10.5688/aj69051526 · Cited by 34
Ethanol concentrations in the human gastrointestinal tract after intake of alcoholic beverages
Rubbens, J., Brouwers, J., Wolfs, K., Adams, E., Tack, J. F., & Augustijns, P. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.02.009 · Cited by 32
Self-citationRose, R. H., Turner, D. B., Neuhoff, S., & Jamei, M. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0099-z · Cited by 32
Holm, R., Müllertz, A., Pedersen, G. P., & Kristensen, H. G. (2001) · Pharmaceutical Research · doi:10.1023/a:1013037927882 · Cited by 31
Food–drug interactions in the summary of product characteristics of proprietary medicinal products
Miguel, M. T. S., Martínez, J. A., & Vargas, E. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0846-9 · Cited by 31
Garlic intake lowers fasting blood glucose: meta-analysis of randomized controlled trials.
Hou, L.-Q., Liu, Y.-H., & Zhang, Y. (2015) · PubMed · doi:10.6133/apjcn.2015.24.4.15 · Cited by 31
Exploring the link between gastric motility and intragastric drug distribution in man
Αbeele, J. V. D., Brouwers, J., Tack, J. F., & Augustijns, P. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.027 · Cited by 31
Self-citationGlaeser, H., Drescher, S., Hofmann, U., Heinkele, G., Somogyi, A. A., Eichelbaum, M. F., & Fromm, M. F. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.04.013 · Cited by 30
The Impact of Lymphatic Transport on the Systemic Disposition of Lipophilic Drugs
Caliph, S. M., Cao, E., Bulitta, J. B., Hu, L., Han, S., Porter, C. J. H., & Trevaskis, N. L. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23597 · Cited by 29
Self-citationStieger, B., Mahdi, Z., & Jäger, W. R. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-105010 · Cited by 29
Age related differences in the plasma kinetics of flavanols in rats
Margalef, M., Iglesias‐Carres, L., Pons, Z., Bravo, F. I., Muguerza, B., & Arola‐Arnal, A. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.11.007 · Cited by 27
Konishi, T., Satsu, H., Hatsugai, Y., Aizawa, K., Inakuma, T., Nagata, S., Sakuda, S., Nagasawa, H., & Shimizu, M. (2004) · BioFactors · doi:10.1002/biof.5520220113 · Cited by 25
White, K. L., Nguyen, G., Charman, W. N., Edwards, G. A., Faassen, W. A., & Porter, C. J. H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154542 · Cited by 25
Self-citationThe Temporal Effect of Food on Tacrine Bioavailability
Welty, D. F., Siedlik, P. H., Posvar, E. L., Selen, A., & Sedman, A. J. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb01970.x · Cited by 21
Insights Into the Different Effects of Food on Intestinal Secretion Using Magnetic Resonance Imaging
Wilkinson‐Smith, V., Major, G., Ashleigh, L., Murray, K. A., Hoad, C. L., Marciani, L., Gowland, P. A., & Spiller, R. E. (2018) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1157 · Cited by 19
Self-citationChan, L. J., Feeney, O. M., Leong, N. J., McLeod, V. M., Porter, C. J. H., Williams, C. C., & Kaminskas, L. M. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00794 · Cited by 18
Self-citationTanno, F. K., Sakuma, S., Masaoka, Y., Kataoka, M., Kozaki, T., Kamaguchi, R., Ikeda, Y., Kokubo, H., & Yamashita, S. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21382 · Cited by 17
Mwebaza, N., Jerling, M., Gustafsson, L. L., Obua, C., Waako, P. J., Mahindi, M., Ntale, M., Beck, O., & Hellgren, U. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12065 · Cited by 16
Patel, J. P., & Brocks, D. R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00983.x · Cited by 15
INR Elevation with Maitake Extract in Combination with Warfarin
Hanselin, M. R., Griend, J. P. V., & Linnebur, S. A. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m510 · Cited by 15
Nakamori, F., Naritomi, Y., Hosoya, K., Moriguchi, H., Tetsuka, K., Furukawa, T. Y., Kadono, K., Yamano, K., Terashita, S., & Teramura, T. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045476 · Cited by 15
Garlic-Induced Surgical Bleeding
Woodbury, A., & Sniecinski, R. M. (2016) · A & A Case Reports · doi:10.1213/xaa.0000000000000403 · Cited by 14
Enteric-coated tablets improve oral bioavailability of DX-9065, a novel anticoagulant
Fujii, Y., Kanamaru, T., Kikuchi, H., Yamashita, S., & Sakuma, S. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.01.003 · Cited by 12
A Case Study of In Silico Modelling of Ciprofloxacin Hydrochloride/Metallic Compound Interactions
Stojković, A., Parojčić, J., Djurić, Z., & Corrigan, O. I. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-0055-x · Cited by 9
Ziółkowski, H., Jasiecka-Mikołajczyk, A., Zuśka-Prot, M., Przybysz, J., Grabowski, T., & JAROSZEWSKI, J. J. (2016) · Poultry Science · doi:10.3382/ps/pew121 · Cited by 9
Cited by
The Bioavailability of Drugs—The Current State of Knowledge
Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A. (2023) · Molecules · doi:10.3390/molecules28248038 · Cited by 391
Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 359
Self-citationRe-thinking functional food development through a holistic approach
Alongi, M., & Anese, M. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104466 · Cited by 278
Bender, A., & Cortes-Ciriano, I. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.11.037 · Cited by 232
Let’s talk about sex: Differences in drug therapy in males and females
Madla, C. M., Gavins, F. K. H., Merchant, H. A., Orlu, M., Murdan, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.014 · Cited by 167
Self-citation
Metadata
- Authors
- Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., Marciani, L., Maruca, A., Parrott, N., Pávek, P., Porter, C. J. H., Reppas, C., van Riet-Nales, D., Rubbens, J., Statelova, M., Trevaskis, N. L., Valentová, K., Vertzoni, M., Čepo, D. V., & Corsetti, M.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 134
- Pages
- 31-59
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2937963363
- Cited by
- 385
- References
- 274
- FWCI
- 40.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.